The Patent Finder

Axon Neuroscience SE

Also on record
Records under this name other than the patents Axon Neuroscience SE holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 4 of 4 · Back to Axon Neuroscience SE

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,485,972Truncated tau proteins
Lapsed on the fee record
Ended Nov 8, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 8, 2024USPTO record
US 8,288,608Transgenic animal expressing alzheimer's tau protein
Term ended
Term ended Jul 9, 2023 · USPTO record
Term endedTerm ended Jul 9, 2023USPTO record
US 9,161,520Transgenic animal expressing Alzheimer's tau protein
Term ended
Term ended Jul 9, 2023 · USPTO record
Term endedTerm ended Jul 9, 2023USPTO record
US 7,446,180Conformationally abnormal forms of tau proteins and specific antibodies thereto
Term ended
Term ended Aug 6, 2022 · USPTO record
Term endedTerm ended Aug 6, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited